For example, the development of SERMs and SERDs was largely based on the development of compounds with high binding affinity to ERα and the effects of these compounds on transcriptional regulation (through estrogen response elements) and overall tissue-specific activities (breast cancer cell growth versus uterine effects such as imbibition). The gene discussed is ESR1; the disease is breast carcinoma.